STVN
Stevanato Group S.p.A.
NYSE · ITHealthcareMedical - Instruments & Supplies
$19.15-0.10%
Price as of Jul 20, 2026
STVN valuation
Stevanato Group S.p.A. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 20.15x
- P/E 2026E
- 22.26x
- P/E 2027E
- 17.74x
- P/E 2028E
- 14.81x
- P/S forward
- 2.90x
Trailing multiples
- P/E TTM
- 32.84x
- PEG TTM
- 0.52x
- Price / book
- 2.99x
- Price / sales
- 3.81x
- Price / cash flow
- 17.58x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 4.09x
- EV / EBITDA
- 16.68x
- EV / EBIT
- 24.69x
- Market cap
- $5.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.